Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AstraZeneca says new antidepressant not ready for pharmaceutical sales in U.S.
medreps
Saturday, November 12, 2011 - 12:57pm
tags:
TC-5214, AstraZeneca, antidepressants
Delay in publication of Sunshine Act regulations persists despite bipartisan pressure
Lexology
Saturday, November 12, 2011 - 12:55pm
tags:
Physician Payment Sunshine Act
Vioxx class action appeal (In Australia)
Lexology
Saturday, November 12, 2011 - 12:54pm
tags:
Merck, Vioxx, lawsuits
Salix Beats On Higher Revenues
Daily Markets
Saturday, November 12, 2011 - 12:47pm
tags:
Salix
Boehringer says about 260 deaths related to Pradaxa
Reuters
Saturday, November 12, 2011 - 12:38pm
tags:
Boehringer Ingelheim, Pradaxa, anti-clotting, oral anti-coagulant
Five Reasons to Own Abbott Labs (video)
CNBC
Saturday, November 12, 2011 - 12:35pm
tags:
Abbott Laboratories
A Dividend Raise 7 Years in the Making
Motley Fool
Saturday, November 12, 2011 - 12:34pm
tags:
Merck
Alimera plunges as FDA asks for new Iluvien trials
Yahoo/AP
Saturday, November 12, 2011 - 12:33pm
tags:
Alimera, Iluvien, pSivida, diabetic macular edema
Scott+Scott LLP Announces Securities Class Action Lawsuit Against Human Genome Sciences, Inc. and Others on Behalf of Investors -- HGSI
Yahoo/GlobeNewswire
Saturday, November 12, 2011 - 12:26pm
tags:
Human Genome Sciences, lawsuits
Lexicon Announces Plans for Rights Offering to Stockholders
Yahoo/PR NewsWire
Saturday, November 12, 2011 - 12:25pm
tags:
Lexicon Pharmaceuticals
Aeterna Zentaris Surprises Again
Motley Fool
Saturday, November 12, 2011 - 12:24pm
tags:
Aeterna Zentaris, Cetrotide, perifosine
Aastrom Biosciences to Hold Research and Development Day Review for Investors on November 17, 2011
Yahoo/GlobeNewswire
Saturday, November 12, 2011 - 12:23pm
tags:
Aastrom Biosciences, ixmyelocel-T
1 Reason the Street Should Expect Big Things From Sequenom
Motley Fool
Saturday, November 12, 2011 - 12:21pm
tags:
Sequenom
Amgen To Trade Ex-Dividend
Forbes
Saturday, November 12, 2011 - 12:19pm
tags:
Amgen
Affymax and Takeda Report Additional Analyses of Peginesatide Phase 3 Studies in Dialysis Patients at the American Society of Nephrology’s Kidney Week 2011
Yahoo/BusinessWire
Saturday, November 12, 2011 - 12:16pm
tags:
peginesatide, chronic kidney disease, dialysis, Affymax, Takeda
FDA, EMA accept Astellas bladder drug for review
Pharma Times, UK
Friday, November 11, 2011 - 1:04pm
tags:
FDA, EMA, overactive bladder, Astellas, mirabegron
FTC Commissioners Spar Over Pay-To-Delay Deals
Pharmalot
Friday, November 11, 2011 - 1:02pm
tags:
FTC, pay-for-delay
J&J Seeds an Ambitious Open R&D Program for Neuroscience
Motley Fool
Friday, November 11, 2011 - 12:45pm
tags:
JNJ, R&D, Neurosciences
5-Star Stocks Poised to Pop: Abbott Labs
Motley Fool
Friday, November 11, 2011 - 12:06pm
tags:
Abbott Laboratories
With IPO pending, Verastem raises $20M
Bizjournals.com
Friday, November 11, 2011 - 12:03pm
tags:
Verastem, IPO

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.